24 Hr urine:
U1 bottle |
|||||||||||||||||
Spot urine / 4 Hr urine:
Plain urine bottle
Minimum urine volume: 10 mL |
|||||||||||||||||
Authorisation code required |
No |
||||||||||||||||
24 Hr available service |
No |
||||||||||||||||
Method |
Immunoassay |
||||||||||||||||
Reference interval |
Urine albumin / creatinine ratio: < 3.0 mg/mmol Cr Urine albumin /
creatinine ratio: < 30 mg/g Cr (Source: Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S): S1 - S127. (PMID: 36272764)) |
||||||||||||||||
Clinical indication |
Early detection of diabetic nephropathy
Investigation and monitoring of renal disease |
||||||||||||||||
Result interpretation |
Urine albumin is elevated in nephrotic syndrome, in other conditions with increased glomerular permeability (e.g. glomerulonephritis), and in urinary tract inflammation. Elevations can be seen in renal failure following diabetic nephropathy or other causes. It can be used instead of urinary protein to detect or monitor these conditions.
Elevation of urine albumin can be a marker of kidney damage and is found in chronic kidney disease (CKD). According to the 'Kidney Disease: Improving Global Outcomes' (KDIGO) guidelines, albuminuria can be used in diagnosis and staging of CKD.
Albuminuria categories in Chronic Kidney Disease (CKD):
Nephrotic syndrome: Urine Alb/Cr Ratio (mg/mmol Cr) × 10 is approximately equivalent to Urine Alb/Cr Ratio (mg/g Cr) or Urine Albumin Excretion Rate (mg/day) Precautions:
Reference:
|
||||||||||||||||
Measurement of uncertainty |
|||||||||||||||||
Frequency of measurement |
Daily |